Benzinga | Nov 9, 2020 07:18AM EST

Seres Therapeutics Q3 EPS $(0.36) Misses $(0.25) Estimate, Sales $1.42M Down From $7.03M YoY

Seres Therapeutics (NASDAQ:MCRB) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.25) by 44 percent. This is a 56.52 percent decrease over losses of $(0.23) per share from the same period last year. The company reported $1.42 million in sales this quarter. This is a 79.85 percent decrease over sales of $7.03 million the same period last year.